Insider · CIK 0001370930

Claiborne Cary J

Reports to the SEC for 5 companies · GLEN ALLEN, VA

sec.gov

Transactions

Companies

Filings

CIK

0001370930

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-04-07	ADILADIAL PHARMACEUTICALS, INC.A Award	Director, Chief Executive Officer	AAward	+38K sh	—	—	40,417
2025-05-29	ADILADIAL PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+138K sh	—	—	138,000
2024-12-05	ADILADIAL PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+350K sh	—	—	350,000
2024-03-25	ADILADIAL PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+60K sh	—	—	60,000
2024-01-15	LADXLadRx Corp · Stock Option (Right to Buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2023-05-23	ADILADIAL PHARMACEUTICALS, INC.A Award	Director, Chief Executive Officer	AAward	+420K sh	—	—	1,520,000
2023-05-23	ADILADIAL PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+300K sh	—	—	300,000
2022-09-20	ADILADIAL PHARMACEUTICALS, INC.A Award	Director, Chief Executive Officer	AAward	+75K sh	$0.42	+$31.5K	1,100,000
2022-09-19	ADILADIAL PHARMACEUTICALS, INC.A Award	Director, Chief Executive Officer	AAward	+25K sh	$0.43	+$10.7K	1,025,000
2022-08-18	ADILADIAL PHARMACEUTICALS, INC.A Award	Director, Chief Executive Officer	AAward	+1M sh	—	—	1,000,000
2022-02-23	ADILADIAL PHARMACEUTICALS, INC. · Employee Stock OptionA Award	Director, Chief Executive Officer	AAward	+6,667 sh	—	—	6,667
2021-12-07	ADILADIAL PHARMACEUTICALS, INC. · Stock optionsA Award	Director, Chief Executive Officer	AAward	+130K sh	—	—	130,000
2021-11-02	ADILADIAL PHARMACEUTICALS, INC. · Stock OptionA Award	Director, Chief Executive Officer	AAward	+60K sh	—	—	60,000
2014-12-16	Sucampo Pharmaceuticals, Inc.S Sale	Former Chief Financial Officer	SSale	−42.9K sh	$12.91	−$554K	2,864
2014-12-16	Sucampo Pharmaceuticals, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Former Chief Financial Officer	MExercise/Conversion	−42.9K sh	—	—	99,987
2014-12-16	Sucampo Pharmaceuticals, Inc.M Exercise/Conversion	Former Chief Financial Officer	MExercise/Conversion	+42.9K sh	$4.07	+$175K	45,764
2014-12-15	Sucampo Pharmaceuticals, Inc.S Sale	Former Chief Financial Officer	SSale	−7,100 sh	$12.89	−$91.5K	2,864
2014-12-15	Sucampo Pharmaceuticals, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Former Chief Financial Officer	MExercise/Conversion	−7,100 sh	—	—	142,887
2014-12-15	Sucampo Pharmaceuticals, Inc.M Exercise/Conversion	Former Chief Financial Officer	MExercise/Conversion	+7,100 sh	$4.07	+$28.9K	9,964
2014-09-11	Sucampo Pharmaceuticals, Inc.Employee Stock Option (Right to Buy)A Award	Former Chief Financial Officer	AAward	+25K sh	—	—	149,987
2014-09-11	Sucampo Pharmaceuticals, Inc.Employee Stock Option (Right to Buy)A Award	Former Chief Financial Officer	AAward	+22K sh	—	—	124,987
2014-06-30	Sucampo Pharmaceuticals, Inc.A Award	Former Chief Financial Officer	AAward	+267 sh	$6.56	+$1,751.52	2,621
2014-03-31	Sucampo Pharmaceuticals, Inc.A Award	Former Chief Financial Officer	AAward	+220 sh	$6.79	+$1,493.8	2,354
2014-02-27	Sucampo Pharmaceuticals, Inc.S Sale	Former Chief Financial Officer	SSale	−2,390 sh	$9.00	−$21.5K	110
2014-02-27	Sucampo Pharmaceuticals, Inc.S Sale	Former Chief Financial Officer	SSale	−110 sh	$9.06	−$996.6	0
2014-02-27	Sucampo Pharmaceuticals, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Former Chief Financial Officer	MExercise/Conversion	−2,500 sh	—	—	102,960
2014-02-27	Sucampo Pharmaceuticals, Inc.M Exercise/Conversion	Former Chief Financial Officer	MExercise/Conversion	+2,500 sh	$4.07	+$10.2K	2,500
2014-01-07	Sucampo Pharmaceuticals, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Former Chief Financial Officer	MExercise/Conversion	−100 sh	—	—	105,460
2014-01-07	Sucampo Pharmaceuticals, Inc.M Exercise/Conversion	Former Chief Financial Officer	MExercise/Conversion	+2,400 sh	$4.41	+$10.6K	2,400
2014-01-07	Sucampo Pharmaceuticals, Inc.M Exercise/Conversion	Former Chief Financial Officer	MExercise/Conversion	+100 sh	$4.07	+$407	2,500
2014-01-07	Sucampo Pharmaceuticals, Inc.S Sale	Former Chief Financial Officer	SSale	−2,500 sh	$9.00	−$22.5K	0
2014-01-07	Sucampo Pharmaceuticals, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Former Chief Financial Officer	MExercise/Conversion	−2,400 sh	—	—	105,560
2013-12-31	Sucampo Pharmaceuticals, Inc.A Award	Former Chief Financial Officer	AAward	+196 sh	$8.93	+$1,750.28	2,134
2013-11-25	Sucampo Pharmaceuticals, Inc.Employee Stock Option (Right to Buy)X Exercise of In-Money	Former Chief Financial Officer	XExercise of In-Money	−12.9K sh	$7.64	−$98.9K	109,947
2013-11-25	Sucampo Pharmaceuticals, Inc.X Exercise of In-Money	Former Chief Financial Officer	XExercise of In-Money	−13K sh	$7.64	−$99.2K	109,898
2013-11-25	Sucampo Pharmaceuticals, Inc.Employee Stock Option (Right to Buy)X Exercise of In-Money	Former Chief Financial Officer	XExercise of In-Money	−49 sh	$7.64	−$374.36	109,898
2013-11-22	Sucampo Pharmaceuticals, Inc.X Exercise of In-Money	Former Chief Financial Officer	XExercise of In-Money	−3,511 sh	$7.46	−$26.2K	122,887
2013-11-22	Sucampo Pharmaceuticals, Inc.Employee Stock Option (Right to Buy)X Exercise of In-Money	Former Chief Financial Officer	XExercise of In-Money	−3,511 sh	$7.46	−$26.2K	122,887
2013-09-30	Sucampo Pharmaceuticals, Inc.A Award	Former Chief Financial Officer	AAward	+253 sh	$5.93	+$1,499.784	1,938
2013-06-28	Sucampo Pharmaceuticals, Inc.A Award	Former Chief Financial Officer	AAward	+280 sh	$6.25	+$1,750.28	1,685
2013-05-24	Sucampo Pharmaceuticals, Inc.Employee Stock Option (Right to Buy)X Exercise of In-Money	Former Chief Financial Officer	XExercise of In-Money	−2,000 sh	$9.00	−$18K	125,865
2013-05-24	Sucampo Pharmaceuticals, Inc.Employee Stock Option (Right to Buy)X Exercise of In-Money	Former Chief Financial Officer	XExercise of In-Money	−8,300 sh	$9.00	−$74.7K	127,865
2013-05-24	Sucampo Pharmaceuticals, Inc.X Exercise of In-Money	Former Chief Financial Officer	XExercise of In-Money	−10.3K sh	$9.00	−$92.7K	125,865
2013-05-21	Sucampo Pharmaceuticals, Inc.S Sale	Former Chief Financial Officer	SSale	−2,400 sh	$9.55	−$22.9K	136,165
2013-05-20	Sucampo Pharmaceuticals, Inc.S Sale	Former Chief Financial Officer	SSale	−2,240 sh	$9.50	−$21.3K	138,565
2013-03-28	Sucampo Pharmaceuticals, Inc.A Award	Former Chief Financial Officer	AAward	+242 sh	$6.21	+$1,503.546	1,405
2012-12-31	Sucampo Pharmaceuticals, Inc.A Award	Former Chief Financial Officer	AAward	+376 sh	$4.66	+$1,750.28	1,163
2012-09-28	Sucampo Pharmaceuticals, Inc.A Award	Former Chief Financial Officer	AAward	+313 sh	$4.78	+$1,495.671	787
2012-06-29	Sucampo Pharmaceuticals, Inc.A Award	Former Chief Financial Officer	AAward	+263 sh	$6.68	+$1,756.445	474
2012-03-30	Sucampo Pharmaceuticals, Inc.A Award	Former Chief Financial Officer	AAward	+211 sh	$7.08	+$1,493.353	211

Recent filings

Accepted (ET)
Apr 94
Claiborne Cary J0001213900-26-042050
SEC(opens sec.gov)
Jun 24
Claiborne Cary J0001213900-25-050017
SEC(opens sec.gov)
Dec 54
Claiborne Cary J0001213900-24-106119
SEC(opens sec.gov)
Mar 274
Claiborne Cary J0001213900-24-026712
SEC(opens sec.gov)
Jan 294
Claiborne Cary J0001493152-24-004138
SEC(opens sec.gov)
May 254
Claiborne Cary J0001213900-23-043111
SEC(opens sec.gov)
Sep 204
Claiborne Cary J0001213900-22-057513
SEC(opens sec.gov)
Aug 224
Claiborne Cary J0001213900-22-050082
SEC(opens sec.gov)
Feb 254
Claiborne Cary J0001213900-22-009419
SEC(opens sec.gov)
Dec 84
Claiborne Cary J0001213900-21-064281
SEC(opens sec.gov)
Nov 34
Claiborne Cary J0001213900-21-056466
SEC(opens sec.gov)
Dec 174
Sucampo Pharmaceuticals, Inc.0001171843-14-005941
SEC(opens sec.gov)
Sep 154
Sucampo Pharmaceuticals, Inc.0001171843-14-004349
SEC(opens sec.gov)

Companies

Address

4870 SADLER ROAD, STE 300

GLEN ALLEN, VA, 23060